Ora Biomedical

Ora Biomedical

•Pre-Seed•Founded 2022•Updated 2 months ago
Bio Tech/Life SciencesHealthtechHealth and wellnessB2CB2B1-5 employees
Actively RaisingVC-Backed FounderVC-Backed Founder

About

Discovering longevity-derived bioactives for UV protection, skin health, and healthy aging through proprietary robotic screening platform. Proven effectiveness—not predictive hype.

Products

Aurevia by Ora

Nature-derived, science-validated cosmeceutical featuring ORB-Y compound with UV protection and anti-aging efficacy. Prevents skin-aging by improving cellular response rather than blocking damage. First commercial expression of the WormBot platform with blinded industry validation completed.

Click to read more

ORB1284

Radioprotective and skin-resilience pharmaceutical compound showing >50% lifespan increase in C. elegans. Lead pharma asset targeting radiation-induced dermatitis in cancer patients. Early efficacy signals in human tissue models with mouse study launched via CRO.

Click to read more

WormBot Platform

Proprietary AI-driven robotic screening platform for longevity-first detection of novel clinical interventions and consumer ingredients. 650,000+ individual lifespan observations across nearly 10,000 molecules. Screens 200+ compounds per week with <1 month from hit to human validation.

Click to read more